Bortezomib will boost the level or influence of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Elevated flibanserin adverse consequences could arise if coadministered with numerous weak CYP3A4 inhibitors. Other effects, such as a skin rash, might not be severe but could trigger issue. Some outcomes may not come https://simongzrka.livebloggs.com/32883293/considerations-to-know-about-cp-866087